{{Rsnum
|rsid=1049606
|Gene=CCND2
|Chromosome=12
|position=4273870
|Orientation=plus
|GMAF=0.3838
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CCND2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 18.8 | 41.1 | 40.2
| HCB | 7.4 | 37.5 | 55.1
| JPT | 11.5 | 53.1 | 35.4
| YRI | 23.8 | 49.0 | 27.2
| ASW | 19.3 | 40.4 | 40.4
| CHB | 7.4 | 37.5 | 55.1
| CHD | 5.5 | 40.4 | 54.1
| GIH | 44.6 | 39.6 | 15.8
| LWK | 17.3 | 45.5 | 37.3
| MEX | 14.0 | 47.4 | 38.6
| MKK | 12.2 | 40.4 | 47.4
| TSI | 17.6 | 51.0 | 31.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=20414251
|Title=CCND2 polymorphisms associated with clearance of HBV Infection
}}

{{PMID|17267408|OA=1
}} Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells.

{{PMID|19258477|OA=1
}} Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.

{{PMID|22004425}} Genetic risk of hepatocellular carcinoma in patients with hepatitis C virus: a case control study.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}